Nicolas Kahn - Concepedia

Author

Nicolas Kahn

Heidelberg University ORCID

Also Known As

Kahn, Kahn, N., Kahn, Nicolas C., Korkut Bostanci, N Kahn, N. Kahn, N., Kahn, N.C. Kahn, Nadia Kahn, Nafeesa Kahn

188

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Heidelberg University German Center for Lung Research University Hospital Heidelberg German Cancer Research Center LungenClinic Grosshansdorf

About

Nicolas Kahn is an author at Heidelberg University specializing in medicine, pathology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	2.1K
2	Health Sciences	3	3	408
3	Cell Biology	3	3	482
4	Social Sciences	1	1	73
5	Child Development	1	1	10

Nicolas Kahn

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
<scp>SARS</scp> ‐CoV‐2 receptor <scp>ACE</scp> 2 and <scp>TMPRSS</scp> 2 are primarily expressed in bronchial transient secretory cells Soeren Lukassen, Robert Lorenz Chua, Timo B. Trefzer, The EMBO Journal	2020	1K
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial Jürgen Behr, Antje Prasse, Michael Kreuter, The Lancet Respiratory Medicine Antifibrotic TherapyAdvanced Lung DiseaseIdiopathic Pulmonary FibrosisPulmonary PharmacologyPulmonary Fibrosis	2021	490
SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells Soeren Lukassen, Robert Lorenz Chua, Timo B. Trefzer, The EMBO Journal Viral PathogenesisImmunologyInfectious Respiratory DiseaseSars-cov-2 Receptor Ace2Viral Structural Protein	2020	408
Combined Endoscopic-Endobronchial Ultrasound-Guided Fine-Needle Aspiration of Mediastinal Lymph Nodes Through a Single Bronchoscope in 150 Patients With Suspected Lung Cancer Felix Herth, Mark Krasnik, Nicolas Kahn, CHEST Journal MedicineMediastinal Lymph NodesThoracic UltrasoundBronchial NeoplasmSingle Bronchoscope	2010	271
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry Jürgen Behr, Antje Prasse, Hubert Wirtz, European Respiratory Journal	2020	165
Fibroblast Activation Protein–Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study Manuel Röhrich, Dominik Leitz, Frederik M. Glatting, Journal of Nuclear Medicine	2021	163
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-Life Experience from a German Tertiary Referral Center for Interstitial Lung Diseases Ute Oltmanns, Nicolas Kahn, Karin Palmowski, Respiration	2014	145
LungPoint—A New Approach to Peripheral Lesions Ralf Eberhardt, Nicolas Kahn, Daniela Gompelmann, Journal of Thoracic Oncology Medical ImagingPeripheral LesionsMultiple Pulmonary NoduleThoracic SurgeryPulmonary Medicine	2010	127
The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry Michael Kreuter, Jeff Swigris, David Pittrow, Respiratory Research	2019	115
Hypoxic Epithelial Necrosis Triggers Neutrophilic Inflammation via IL-1 Receptor Signaling in Cystic Fibrosis Lung Disease Benedikt Fritzsching, Zhe Zhou-Suckow, Joanna Trojanek, American Journal of Respiratory and Critical Care Medicine	2015	105

Page 1